[PDF] Top 20 Update on cell therapy for stroke
Has 10000 "Update on cell therapy for stroke" found on our website. Below are the top 20 most common "Update on cell therapy for stroke".
Update on cell therapy for stroke
... after stroke, the intravenous route might be best as a neuroprotec- tive or anti-inflammatory ...chronic stroke, direct intracerebral injection is likely necessary to delivery cells to brain areas ... See full document
6
Brain repair: cell therapy in stroke
... cases. Cell therapy offers a potential for multimodal action that is promising within the domain of brain repair ...animal stroke studies, stem cell experiments have shown evidence of ... See full document
14
An update on stem cell therapy for neurological disorders: cell death pathways as therapeutic targets
... stem cell therapy in traumatic brain injury [26, 27] and in stroke [28, ...this cell therapy over the last two decades and raised public concern, including safety measures, ... See full document
8
The spleen may be an important target of stem cell therapy for stroke
... immunomodulatory therapy based on intravenous cells is attracting ...acute stroke is a major factor in cerebral ischaemia (CI) pathobiology and ...ischaemic stroke has gained considerable attention ... See full document
24
The potential benefit of stem cell therapy after stroke: an update
... stem cell trials completed to date means that it is difficult to make any meaningful comparisons between ...The Stroke Therapy Academic Industry Roundtable (STAIR) II meeting elucidated the important ... See full document
12
Neural stem cell therapy for subacute and chronic ischemic stroke
... from stroke is ultimately a result of mass cell death and tissue loss in the ...of stroke and engrafted animals showed improved functional and behavioral recovery [176, 226, ...after stroke in ... See full document
17
Dental pulp stem cells : an attractive alternative for cell therapy in ischemic stroke
... different cell types is hard to establish due to inevitable differences regarding the conditions in which the cells are prepared and processed ...recipient cell signaling pathways), adhesion molecules and ... See full document
10
Stem Cell Therapy for Stroke, Recent Advances, Controversies and Literature Review
... Bone marrow and umbilical cord stem cells have surged as an alternative viable approach for treating neurological stroke disease [42]. These cells can exhibit neuronal or glial differentiation and have mediated ... See full document
9
New directions in cardiac stem cell therapy: An update for clinicians
... improve cell survival is pre- treatment of the cells prior to ...improved cell viability, and an in vivo study in the rat MI model found 25% reduction in infarct size with use of the preconditioned cells ... See full document
8
Stem cell therapy for retinal diseases: update
... A number of studies have shown that BM-derived MSCs can diff erentiate into cells expressing photo- receptor proteins when injected into the subretinal space [37,38]. Interestingly, it has been suggested that rat MSCs can ... See full document
10
Combination therapy in hypertension: An update
... Achieving recommended goal of blood pressure (BP) {< 140/90 mmHg in all hypertensives, < 130/80 mm Hg in hypertensives with diabetes mellitus (DM) [1]} is difficult in majority of patients with hypertension [2]. ... See full document
11
Stem cell tourism in South Africa: A legal update
... stem cell research requires a consideration of difficult questions relating to social and distributive justice, in particular as far as access to these treatments is ...to cell therapy as a ... See full document
5
Update on mesenchymal stem cell based therapy in lupus and scleroderma
... Stem Cell Committee of International Society for Cellular Therapy (ISCT) was changed to “multipotent mesenchymal stro- mal ...their cell surface and have no detectable levels of MHC class II, mainly ... See full document
9
Update on vaccine development for renal cell cancer
... Renal cell carcinoma (RCC) vaccine trials: summary of clinical and immunologic monitoring ...to therapy: CR, complete response; PR, partial response; SD, stable ... See full document
17
B cell targeted therapy for systemic lupus erythematosus: an update
... prednisone therapy was also seen in patients treated with modalities, should be determined by future randomized controlled belimumab than with placebo (7% vs 15%; p < ... See full document
12
Novel stem cell and gene therapy in diabetic retinopathy, age related macular degeneration, and retinitis pigmentosa
... stem cell and gene therapy may also reverse the effects of these, and other, degenerative retinal ...will update the reader on aspects of stem cell and gene therapy in diabetic ... See full document
14
Twenty years of limbal epithelial therapy: an update on managing limbal stem cell deficiency
... stem cell damage after chemical injury, autoimmune disorders or iatrogenic trauma leads to corneal conjunctivalisation with new vessel formation, epithelium instability and visual ...stem cell ... See full document
7
Novel Therapy for Oral Cancer - Gene Therapy an Update
... Squamous Cell Carcinoma (OSCC) is one of the most common malignancy seen globally [5] and it ranks 6 th amongst all cancer worldwide ...the cell growth and apoptosis are mutated and the cells invade into ... See full document
8
Update on targeted therapies for advanced non-small cell lung cancer: nivolumab in context
... non-small cell lung cancer (NSCLC) being the most common ...radiation therapy, recent advances in understanding of cancer biology and immunology have spurred the development of numerous targeted therapies ... See full document
14
Mesenchymal stem cell-based therapy for ischemic stroke
... include cell replacement, growth factor secretion, and biobridge formation ...[59]. Stroke therapeutics have been categorized as ‘neuroprotective’ for the acute phase or ‘neuroregenerative’ for the subacute ... See full document
6
Related subjects